
Academic Journal
Q1Cancer and Metastasis Reviews
About Cancer and Metastasis Reviews
Cancer and Metastasis Reviews is a scholarly journal published by Springer. SCImago 2025 lists it in Q1, with an SJR of 3.223 and H-index of 182.
Coverage: 1982-2026. Research categories: Cancer Research (Q1); Oncology (Q1).
Verified field sources
- Journal Impact Factor: 12.7 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Erica A. Golemis PhD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Cancer Cells and Metastasis; Cancer, Hypoxia, and Metabolism; Cancer Genomics and Diagnostics; Cell Adhesion Molecules Research; Angiogenesis and VEGF in Cancer; Cancer Immunotherapy and Biomarkers.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,790.00 USD; 2,890.00 EUR; 2,490.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings
Deepa Sharma, Gregory J. Czarnota
2025-03 · DOI: 10.1007/s10555-025-10255-5The functions and modifications of tRNA-derived small RNAs in cancer biology
Abdulaziz Ahmed A. Saad, Kun Zhang, Qianqian Deng, Jiawang Zhou et al.
2025-03 · DOI: 10.1007/s10555-025-10254-6Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
2025-03 · DOI: 10.1007/s10555-025-10253-7Ferroptosis: iron release mechanisms in the bioenergetic process
Jaewang Lee, Jong-Lyel Roh
2025-03 · DOI: 10.1007/s10555-025-10252-8Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis
Aiarpi Ezdoglian, Michel Tsang-A-Sjoe, Fatemeh Khodadust, George Burchell et al.
2025-03 · DOI: 10.1007/s10555-025-10246-6Mitochondrial alterations and signatures in hepatocellular carcinoma
Tsung-Hsien Chen, Shu-Hsien Lin, Ming-Yang Lee, Hsiang-Chen Wang et al.
2025-03 · DOI: 10.1007/s10555-025-10251-9p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair
Xiaojuan Yang, Xunjie Cao, Qing Zhu
2025-03 · DOI: 10.1007/s10555-025-10250-wCTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting
Priya Ghosh, Ankita Dey, Suvendu Nandi, Ranabir Majumder et al.
2025-03 · DOI: 10.1007/s10555-025-10248-4Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer
Hanan Bloomer, Haley B. Dame, Savannah R. Parker, Madeleine J. Oudin et al.
2025-03 · DOI: 10.1007/s10555-025-10249-3Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy
Maritza Ramos-Ramírez, Enrique Caballe-Pérez, José Lucio-Lozada, Eunice Romero-Nuñez et al.
2025-03 · DOI: 10.1007/s10555-025-10245-7Minimally invasive biomarkers for triaging lung nodules—challenges and future perspectives
Waqar Ahmed Afridi, Samandra Hernandez Picos, Juliana Muller Bark, Danyelle Assis Ferreira Stamoudis et al.
2025-03 · DOI: 10.1007/s10555-025-10247-5Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art
Anna Gueiderikh, Jean-Christophe Faivre, Constance Golfier, Alexandre Escande et al.
2025-03 · DOI: 10.1007/s10555-024-10236-0Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies
Sarra Mestiri, Ana Sami, Naresh Sah, Dina Moustafa Abo El-Ella et al.
2025-03 · DOI: 10.1007/s10555-025-10244-8The diversity of natural killer cell functional and phenotypic states in cancer
Kumar Rishabh, Sandro Matosevic
2025-03 · DOI: 10.1007/s10555-025-10242-wSympathetic nerve signaling rewires the tumor microenvironment: a shift in “microenvironmental-ity”
Ariana Sattler, Tetiana Korzun, Kasmira Gupta, Parham Diba et al.
2025-03 · DOI: 10.1007/s10555-025-10241-xAdvancements in gene therapies targeting mutant KRAS in cancers
Yuhang Wang, Thuy Anh Bui, Xinpu Yang, Gyorgy Hutvagner et al.
2025-03 · DOI: 10.1007/s10555-025-10243-9LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance
Wanqi Wang, Noor A. Lokman, Simon C. Barry, Martin K. Oehler et al.
2025-03 · DOI: 10.1007/s10555-024-10239-xThe transcription factor FOXQ1 in cancer
Stefan Koch
2025-03 · DOI: 10.1007/s10555-025-10240-yNeuropeptide Y in cancer—biological functions and potential clinical implications
Dawid Sigorski, Aleksandra Sejda, Nouran Abualsaud, Ewa Krawczyk et al.
2025-03 · DOI: 10.1007/s10555-024-10237-zRecapitulating the potential contribution of protein S-palmitoylation in cancer
Suchi Chaturvedi, Avinash Sonawane
2025-03 · DOI: 10.1007/s10555-024-10217-3Reviews
Community Reviews
Version History
September 14, 2026 at 11:45 am
September 14, 2026